Gabriel A. de Erausquin, M.D., Ph.D., M.Sc.
Gabriel A. de Erausquin, M.D., Ph.D., M.Sc.
UTHSCSA School of Medicine
Verified email at - Homepage
Cited by
Cited by
Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies
J Arnedo, DM Svrakic, C Del Val, R Romero-Zaliz, H Hernández-Cuervo, ...
American Journal of Psychiatry, 2015
Down-regulation of protein kinase C protects cerebellar granule neurons in primary culture from glutamate-induced neuronal death
M Favaron, H Manev, R Siman, M Bertolino, AM Szekely, G DeErausquin, ...
Proceedings of the National Academy of Sciences 87 (5), 1983-1987, 1990
SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT
A Abi-Dargham, MS Gandelman, GA DeErausquin, Y Zea-Ponce
The Journal of Nuclear Medicine 37 (7), 1129, 1996
Structural analysis of the basal ganglia in schizophrenia
D Mamah, L Wang, D Barch, GA de Erausquin, M Gado, JG Csernansky
Schizophrenia research 89 (1-3), 59-71, 2007
Gangliosides normalize distorted single-cell intracellular free Ca2+ dynamics after toxic doses of glutamate in cerebellar granule cells.
GA De Erausquin, H Manev, A Guidotti, E Costa, G Brooker
Proceedings of the National Academy of Sciences 87 (20), 8017-8021, 1990
What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia
GA De Erausquin, L Alba-Ferrara
Frontiers in integrative neuroscience 7, 9, 2013
Repetitive hypoglycemia in young rats impairs hippocampal long-term potentiation
KA Yamada, N Rensing, Y Izumi, GA De Erausquin, V Gazit, DA Dorsey, ...
Pediatric research 55 (3), 372-379, 2004
A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51
JC O'Leary III, S Dharia, LJ Blair, S Brady, AG Johnson, M Peters, ...
PloS one 6 (9), e24840, 2011
No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia
A Abi-Dargham, M Laruelle, J Krystal, C D'Souza, S Zoghbi, RM Baldwin, ...
Neuropsychopharmacology 20 (6), 650-661, 1999
Plastic elimination of functional glutamate release sites by depolarization
KL Moulder, JP Meeks, AA Shute, CK Hamilton, G De Erausquin, ...
Neuron 42 (3), 423-435, 2004
Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6‐OHDA rat model of Parkinson’s disease
A Anastasía, L Torre, GA De Erausquin, DH Mascó
Journal of neurochemistry 109 (3), 755-765, 2009
Cognitive disturbances in primary blepharospasm
GG Alemán, GA De Erausquin, F Micheli
Movement disorders: official journal of the Movement Disorder Society 24 (14 …, 2009
Calcium homeostasis, free radical formation, and trophic factor dependence mechanisms in Parkinson's disease.
GA De Erausquin, E Costa, I Hanbauer
Pharmacological reviews 46 (4), 467-482, 1994
Nuclear translocation of nuclear transcription factor-κB by α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in …
GA De Erausquin, K Hyrc, DA Dorsey, D Mamah, M Dokucu, DH Mascó, ...
Molecular pharmacology 63 (4), 784-790, 2003
Amiloride blocks glutamate-operated cationic channels and protects neurons in culture from glutamate-induced death
H Manev, M Bertolino, G DeErausquin
Neuropharmacology 29 (12), 1103-1110, 1990
Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease
SD Tabbal, FJ Revilla, JW Mink, P Schneider-Gibson, AR Wernle, ...
Operative Neurosurgery 61 (suppl_3), ONS-119-ONS-129, 2007
Decomposition of brain diffusion imaging data uncovers latent schizophrenias with distinct patterns of white matter anisotropy
J Arnedo, D Mamah, DA Baranger, MP Harms, DM Barch, DM Svrakic, ...
Neuroimage 120, 43-54, 2015
Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics
SA Strejilevich, A Palatnik, R Avila, J Bustin, J Cassone, S Figueroa, ...
Psychiatry Research 133 (2-3), 277-280, 2005
Synapse loss and regeneration: A mechanism for functional decline and recovery after cerebral ischemia?
MJ Hasbani, SM Underhill, G De Erausquin, MP Goldberg
The Neuroscientist 6 (2), 110-119, 2000
Differential effects of excitatory amino acids on mesencephalic neurons expressing either calretinin or tyrosine hydroxylase in primary cultures
KR Isaacs, G De Erausquin, KI Strauss, DM Jacobowitz, I Hanbauer
Molecular brain research 36 (1), 114-126, 1996
The system can't perform the operation now. Try again later.
Articles 1–20